Simultaneously, the methylation level of FERMT1 gradually decreased with the development of PAAD, and the lowest methylation status was implied in stage 1 and grade 1 tumors (Figure 4C,D). The gene discussed is FERMT1; the disease is pancreatic adenocarcinoma.